Literature DB >> 16172152

British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-{alpha} treatments.

J Ledingham, C Wilkinson, C Deighton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16172152     DOI： 10.1093/rheumatology/kei103

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases.

Authors:  José M Ramos; Mar Masiá; Juan C Rodríguez; Cristina López; Sergio Padilla; Catalina Robledano; Francisco J Navarro-Blasco; Jaime Matarredona; Mariana F García-Sepulcre; Félix Gutiérrez
Journal:  Clin Exp Med       Date:  2012-06-27       Impact factor: 3.984

Review 2.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases.

Authors:  Hyun-Ju Jung; Tae-Jong Kim; Hyoung-Sang Kim; Young-Nan Cho; Hye-Mi Jin; Moon-Ju Kim; Jeong-Hwa Kang; Ki-Jeong Park; Sung-Ji Lee; Shin-Seok Lee; Yong-Soo Kwon; Dae-Hyun Yoo; Seung-Jung Kee; Yong-Wook Park
Journal:  Rheumatol Int       Date:  2014-05-12       Impact factor: 2.631

4.  Prevalence of positive ppd in a cohort of rheumatoid arthritis patients.

Authors:  Maria Natalia Tamborenea; Guillermo Tate; Eduardo Mysler; Jose Debonis; Adrian Schijedman
Journal:  Rheumatol Int       Date:  2009-07-04       Impact factor: 2.631

5.  Follow-up results of 702 patients receiving tumor necrosis factor-α antagonists and evaluation of risk of tuberculosis.

Authors:  Tulin Cagatay; Munevver Aydin; Sule Sunmez; Penbe Cagatay; Ziya Gulbaran; Ahmet Gul; Bahar Artim; Zeki Kilicaslan
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

6.  Minimizing Tuberculosis Risk in Patients Receiving Anti-TNF Therapy.

Authors:  Hanif Esmail; Robert J Wilkinson
Journal:  Ann Am Thorac Soc       Date:  2017-05

7.  Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review.

Authors:  Abdellah El Maghraoui; Mohamed Dehhaoui
Journal:  Pulm Med       Date:  2012-02-22

8.  Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases.

Authors:  Junhee Pyo; Soo-Kyung Cho; Dam Kim; Yoon-Kyoung Sung
Journal:  Korean J Intern Med       Date:  2017-12-28       Impact factor: 2.884

9.  Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.

Authors:  Anja Strangfeld; Franka Hierse; Rolf Rau; Gerd-Ruediger Burmester; Brigitte Krummel-Lorenz; Winfried Demary; Joachim Listing; Angela Zink
Journal:  Arthritis Res Ther       Date:  2010-01-08       Impact factor: 5.156

10.  Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population.

Authors:  Eun Young Kim; Ju Eun Lim; Ji Ye Jung; Ji Young Son; Kyung Jong Lee; Yoe Wun Yoon; Byung Hoon Park; Jin Wook Moon; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Young Ae Kang
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.